RETRO-POPE: A Retrospective, Multicenter, Real-World Study of All-Cause Mortality in COPD.

"Disclosure VK reports non-financial support from Meditech Media, UK, Boehringer Ingelheim RCV Vienna, AUT, Charles University, Czechia, and Ministry of the Health, Czechia, during the conduct of the study. He gave presentations at symposia and sponsored and received fees for advisory board participation and travel grants from Angelini, AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi and Menarini. He received research grants from Angelini, AstraZeneca, Boehringer Ingelheim and Chiesi. BM has received honoraria for consulting and presenting from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim and Novartis. BM also reports grants from Company Providens, Serbia, non-financial support for Advisory Board for COPD from AstraZeneca, Serbia and Boehringer Ingelheim, outside the submitted work; and President of Respiratory Society of Serbia and President of Republic Expert Commission for Pulmonology (by Ministry of Health Republic of Serbia). MS, JK, SH, VZ, MI, JJank and JJark have nothing to disclose. VC has received honoraria for consulting and presenting from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim and Teva. BP is an employee of Boehringer Ingelheim Serbia d.o.o Beograd. AV has received speaker and/or consultancy fees, as well as research grants from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Menarini and Novartis."

"The RETRO-POPE post hoc analysis was supported by the Cooperatio Program of Charles University, Czechia - EU, research area INDI, and UHHK, 00179906 and Boehringer Ingelheim, RCV GmbH & Co KG."